Advertisement

Sleep Disturbances and Resistant Hypertension: Association or Causality?

  • Daniel Castanho Genta-Pereira
  • Rodrigo P. Pedrosa
  • Geraldo Lorenzi-Filho
  • Luciano F. DragerEmail author
Resistant Hypertension (E Pimenta, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Resistant Hypertension

Abstract

Two main sleep disturbances, namely obstructive sleep apnea (OSA) and sleep deprivation, have gained growing interest in the field of hypertension research. This fact is supported not only by evidence that both disturbances are quite common in modern societies but also that OSA and sleep deprivation are associated with several pathways that may contribute to a predisposition to hypertension or even exacerbate blood pressure levels in hypertensive patients. In the present review, we will discuss current evidence supporting a potential role of these sleep disturbances in the resistant hypertension scenario.

Keywords

Cardiovascular risk Hypertension Sleep apnea Sleep deprivation Sleep disturbances 

Notes

Compliance with Ethics Guidelines

Conflict of Interest Daniel Castanho Genta-Pereira, Rodrigo P. Pedrosa, Geraldo Lorenzi-Filho, and Luciano F. Drager declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.•
    Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–14. This is an update of the prevalence of sleep-disordered breathing in US adults. Comparing data from 2 decades ago, the current estimates represent an increase of millions of additional afflicted persons and are mainly explained by the ongoing obesity epidemic.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217–39.PubMedGoogle Scholar
  3. 3.
    Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol. 2005;99:1592–9.PubMedGoogle Scholar
  4. 4.
    Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32:1017–9.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Johansson P, Alehagen U, Svanborg E, Dahlström U, Broström A. Sleep disordered breathing in an elderly community-living population: relationship to cardiac function, insomnia symptoms and daytime sleepiness. Sleep Med. 2009;10(9):1005–11.PubMedGoogle Scholar
  6. 6.
    Sjöström C, Lindberg E, Elmasry A, Hägg A, Svärdsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax. 2002;57:602–7.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger EM, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol. 2010;105(8):1135–9.PubMedGoogle Scholar
  8. 8.•
    Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811–7. This study performed a systematic evaluation of secondary forms of hypertension in 125 consecutive patients with resistant hypertension from two Cardiology Centers. Obstructive Sleep Apneas was by far the most common condition associated with resistant hypertension, even considering a conservative diagnosis criteria (≥15 events/hour of sleep).PubMedGoogle Scholar
  9. 9.
    Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271–7.PubMedGoogle Scholar
  10. 10.
    Florczak E, Prejbisz A, Szwench-Pietrasz E, Sliwiński P, Bieleń P, Klisiewicz A, et al. Clinical characteristics of patients with resistant hypertension: the RESIST-POL study. J Hum Hypertens. 2013;27(11):678–85.PubMedGoogle Scholar
  11. 11.•
    Muxfeldt ES, Margallo VS, Guimarães GM, Salles GF. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens. 2014. doi: 10.1007/s801090000086. Cross-sectional analysis with 422 resistant hypertensive patients submitted to a full-night polysomnography in a single cardiology center. Beyond a high prevalence of obstructive sleep apnea, the authors found that patients with moderate/severe OSA had an adverse ambulatory blood pressure profile, with higher nighttime systolic blood pressures and pulse pressures and higher prevalence of nondipping patterns.
  12. 12.
    Pedrosa RP, Krieger EM, Lorenzi-Filho G, Drager LF. Recent advances of the impact of obstructive sleep apnea on systemic hypertension. Arq Bras Cardiol. 2011;97:e40–7.PubMedGoogle Scholar
  13. 13.
    Konecny T, Kara T, Somers VK. Obstructive sleep apnea and hypertension: an update. Hypertension. 2014;63:203–9.PubMedGoogle Scholar
  14. 14.•
    Abboud F, Kumar R. Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity. J Clin Invest. 2014;124(4):1454–7. Interesting review approaching the importance and mechanisms of sympathetic activation in obstructive sleep apnea.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Marcus JA, Pothineni A, Marcus CZ, Bisognano JD. The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension. Curr Hypertens Rep. 2014;16(1):411.PubMedGoogle Scholar
  16. 16.
    Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897–904.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Prabhakar NR, Peng YJ, Kumar GK, Nanduri J, Di Giulio C, Lahiri S. Long-term regulation of carotid body function: acclimatization and adaptation–invited article. Adv Exp Med Biol. 2009;648:307–17.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009;54:375–85.PubMedGoogle Scholar
  19. 19.
    Gjørup PH, Wessels J, Pedersen EB. Abnormally increased nitric oxide synthesis and increased endothelin-1 in plasma in patients with obstructive sleep apnoea. Scand J Clin Lab Invest. 2008;68(5):375–85.PubMedGoogle Scholar
  20. 20.
    Gjørup PH, Sadauskiene L, Wessels J, Nyvad O, Strunge B, Pedersen EB. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens. 2007;20(1):44–52.PubMedGoogle Scholar
  21. 21.
    Yüksel M, Okur HK, Pelin Z, AV OÜ, Oztürk L. Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome. Clinics (Sao Paulo). 2014;69(4):247–52.Google Scholar
  22. 22.
    Jelic S, Lederer DJ, Adams T, et al. Vascular inflammation in obesity and sleep apnea. Circulation. 2010;121:1014–21.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117(17):2270–8.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor P, et al. Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea. Vasc Health Risk Manag. 2009;5:909–20.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2005;172(5):613–8.PubMedGoogle Scholar
  26. 26.
    Phillips CL, Butlin M, Wong KK, Avolio AP. Is obstructive sleep apnoea causally related to arterial stiffness? A critical review of the experimental evidence. Sleep Med Rev. 2013;17(1):7–18.PubMedGoogle Scholar
  27. 27.
    Doonan RJ, Scheffler P, Lalli M, Kimoff RJ, Petridou ET, Daskalopoulos ME, et al. Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res. 2011;34(1):23–32.PubMedGoogle Scholar
  28. 28.
    Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176(7):706–12.PubMedGoogle Scholar
  29. 29.
    Vlachantoni IT, Dikaiakou E, Antonopoulos CN, Stefanadis C, Daskalopoulou SS, Petridou ET. Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev. 2013;17(1):19–28.PubMedGoogle Scholar
  30. 30.
    Kartali N, Daskalopoulou E, Geleris P, Chatzipantazi S, Tziomalos K, Vlachogiannis E, et al. The effect of continuous positive airway pressure therapy on blood pressure and arterial stiffness in hypertensive patients with obstructive sleep apnea. Sleep Breath. 2013. doi: 10.1007/s11325-013-0926-0.PubMedGoogle Scholar
  31. 31.
    Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131(5):1379–86.PubMedGoogle Scholar
  32. 32.
    Pickering TG. Arterial stiffness as a cause of resistant hypertension? J Clin Hypertens (Greenwich). 2007;9(5):390–5.Google Scholar
  33. 33.
    Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol (1985). 2002;92(2):627–33.Google Scholar
  34. 34.
    Møller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens. 2003;16(4):274–80.PubMedGoogle Scholar
  35. 35.
    Foster GE, Hanly PJ, Ahmed SB, Beaudin AE, Pialoux V, Poulin MJ. Intermittent hypoxia increases arterial blood pressure in humans through a Renin-Angiotensin system-dependent mechanism. Hypertension. 2010;56(3):369–77.PubMedGoogle Scholar
  36. 36.
    Sim JJ, Yan EH, Liu IL, Rasgon SA, Kalantar-Zadeh K, Calhoun DA, et al. Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population. J Hypertens. 2011;29(8):1553–9.PubMedGoogle Scholar
  37. 37.
    Barceló A, Piérola J, Esquinas C, de la Peña M, Arqué M, Alonso-Fernández A, et al. Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment. PLoS One. 2014;9(1):e84362.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Knight WD, Saxena A, Shell B, Nedungadi TP, Mifflin SW, Cunningham JT. Central losartan attenuates increases in arterial pressure and expression of FosB/ΔFosB along the autonomic axis associated with chronic intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol. 2013;305(9):R1051–8.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Svatikova A, Olson LJ, Wolk R, Phillips BG, Adachi T, Schwartz GL, et al. Obstructive sleep apnea and aldosterone. Sleep. 2009;32(12):1589–92.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest. 2007;131(2):453–9.PubMedGoogle Scholar
  41. 41.
    Chiu KL, Ryan CM, Shiota S, Ruttanaumpawan P, Arzt M, Haight JS, et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med. 2006;174:1378–83.PubMedGoogle Scholar
  42. 42.
    Shiota S, Ryan CM, Chiu KL, Ruttanaumpawan P, Haight J, Arzt M, et al. Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects. Thorax. 2007;62:868–72.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Su MC, Chiu KL, Ruttanaumpawan P, Shiota S, Yumino D, Redolfi S, et al. Lower body positive pressure increases upper airway collapsibility in healthy subjects. Respir Physiol Neurobiol. 2008;161:306–12.PubMedGoogle Scholar
  44. 44.
    Friedman O, Bradley TD, Chan CT, Parkes R, Logan AG. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension. 2010;56:1077–82.PubMedGoogle Scholar
  45. 45.
    Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131(7):485–91.PubMedGoogle Scholar
  46. 46.
    Gus M, Gonçalves SC, Martinez D, de Abreu Silva EO, Moreira LB, Fuchs SC, et al. Risk for obstructive sleep apnea by Berlin Questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study. Am J Hypertens. 2008;21(7):832–5.PubMedGoogle Scholar
  47. 47.
    Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417–23.PubMedGoogle Scholar
  48. 48.
    Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007;185(2):67–72.PubMedGoogle Scholar
  49. 49.
    Fava C, Dorigoni S, Dalle Vedove F, Danese E, Montagnana M, Guidi GC, et al. Effect of continuous positive airway pressure (CPAP) on blood pressure in patients with obstructive sleep apnea/hypopnea. A systematic review and meta-analysis. Chest. 2014;145(4):762–71.PubMedGoogle Scholar
  50. 50.
    Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J. 2003;21(2):241–7.PubMedGoogle Scholar
  51. 51.
    Martínez-García MA, Gómez-Aldaraví R, Soler-Cataluña JJ, Martínez TG, Bernácer-Alpera B, Román-Sánchez P. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J. 2007;29(5):951–7.PubMedGoogle Scholar
  52. 52.
    Dernaika TA, Kinasewitz GT, Tawk MM. Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea: effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med. 2009;5(2):103–7.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Lozano L, Tovar JL, Sampol G, Romero O, Jurado MJ, Segarra A, et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens. 2010;28:2161–8.PubMedGoogle Scholar
  54. 54.•
    Pedrosa RP, Drager LF, de Paula LKG, Amaro ACS, Bortolotto LA, Lorenzi-Filho G. Effects of OSA treatment on BP in patients with resistant hypertension. Chest. 2013;144:1487–94. First randomized study specifically devoted to explore the impact of CPAP in patients with resistant hypertension and moderate to severe obstructive sleep apnea.PubMedGoogle Scholar
  55. 55.
    Garcia CE, Drager LF, Krieger EM, Negrão CE, Bortolotto LA, Lorenzi-Filho G, et al. Arousals are frequent and associated with exacerbated blood pressure response in patients with primary hypertension. Am J Hypertens. 2013;26:617–23.PubMedGoogle Scholar
  56. 56.
    Kuo TB, Chen CY, Lai CT, Chuan TY, Wu WY, Tsai SC, et al. Sleep disturbance among spontaneously hypertensive rats is mediated by an α1-adrenergic mechanism. Am J Hypertens. 2012;25:1110–7.PubMedGoogle Scholar
  57. 57.•
    Martínez-García MA et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension - the HIPARCO Randomized Clinical Trial. JAMA. 2013;310(22):2407–15. Multicentric study performed in Spain evaluating the impact of CPAP involving 194 patients with resistant hypertension and moderate to severe obstructive sleep apnea.PubMedGoogle Scholar
  58. 58.
    Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens. 2010;24(8):532–7.PubMedGoogle Scholar
  59. 59.
    Kasai T, Bradley TD, Friedman O, Logan AG. Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension. J Hypertens. 2014;32(3):673–80.PubMedGoogle Scholar
  60. 60.
    Witkowski A, Prejbisz A, Florczak E, Kądziela J, Śliwiński P, Bieleń P, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58(4):559–65.PubMedGoogle Scholar
  61. 61.
    Kasai T, Floras JS, Bradley TD. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation. 2012;126(12):1495–510.PubMedGoogle Scholar
  62. 62.
    Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47(5):833–9.PubMedGoogle Scholar
  63. 63.
    Cappuccio FP, Stranges S, Kandala N-B, Miller MA, Taggart FM, Kumari M, et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension. The Whitehall II Study. Hypertension. 2007;50:694–701.Google Scholar
  64. 64.
    Stang A, Moebus S, Möhlenkamp S, Erbel R, Jöckel KH, Heinz Nixdorf Recall Study Investigative Group. Gender-specific associations of short sleep duration with prevalent hypertension. Hypertension. 2008;51(3):e15–6. author reply e17.PubMedGoogle Scholar
  65. 65.
    Dettoni JL, Consolim-Colombo FM, Drager LF, Rubira MC, Souza SB, Irigoyen MC, et al. Cardiovascular effects of partial sleep deprivation in healthy volunteers. J Appl Physiol (1985). 2012;113(2):232–6.Google Scholar
  66. 66.
    Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43(4):678–83.PubMedGoogle Scholar
  67. 67.•
    Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569–76. Comprehensive review approaching the potential impact of obstructive sleep apnea in exacerbating the cardiovascular risk in patients with obesity and the metabolic syndrome.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Jenner R, Lorenzi-Filho G, Drager LF. Cardiovascular impact of obstructive sleep apnea: does gender matter? Expert Rev Cardiovasc Ther. 2014;12(3):281–3.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Daniel Castanho Genta-Pereira
    • 1
  • Rodrigo P. Pedrosa
    • 2
  • Geraldo Lorenzi-Filho
    • 3
  • Luciano F. Drager
    • 1
    • 4
    Email author
  1. 1.Hypertension Unit, Heart Institute (InCor)University of São Paulo Medical SchoolSão PauloBrazil
  2. 2.Sleep and Heart LaboratoryPronto Socorro Cardiológico de Pernambuco (PROCAPE) da Universidade de PernambucoRecifeBrazil
  3. 3.Sleep Laboratory, Pulmonary Division, Heart Institute (InCor)University of São Paulo Medical SchoolSão PauloBrazil
  4. 4.Hypertension Unit, Nephrology DivisionUniversity of São Paulo Medical SchoolSão PauloBrazil

Personalised recommendations